Dr Andrew Rut at MyMeds&Me outlines to ICT Magazine the ways in which pharmaceutical companies must approach patient data safety in clinical trials
GDPR: It’s impact on the healthcare sector and how Pharma companies can prepare
Dr. Andrew Rut, CEO of MyMeds&Me to be panelist at the pvlegal Biannual Meeting
Dr. Andrew Rut, CEO of MyMeds&Me speaks to The Pharma Letter
Is Big Data Always Good Data?
MyMeds&Me attend DIA Global Meeting 2018 in Boston
Dr. Andrew Rut, CEO of MyMeds&Me, will be speaking at FutureLink Conference in Munich
Andrew Rut, CEO of MyMeds&Me shares his thoughts on Brexit’s impact on clinical trials
For expert insight and updates from the MyMeds&Me team.
We respect your privacy and we will only use your email address for newsletters and company updates
To find out more or request a demo fill in the details below: